Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Predicting MCI outcome with clinically available MRI and CSF biomarkers.

Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2011 Oct 25;77(17):1619-28. doi: 10.1212/WNL.0b013e3182343314. Epub 2011 Oct 12.

2.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
3.

Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?

Mitchell AJ, Monge-Argilés JA, Sánchez-Paya J.

Pract Neurol. 2010 Aug;10(4):202-7. doi: 10.1136/jnnp.2010.217778. Review.

PMID:
20647526

Supplemental Content

Support Center